1.
Drug Intell Clin Pharm
; 19(7-8): 548-9, 1985.
Article
in English
| MEDLINE
| ID: mdl-4028958
ABSTRACT
A case report of amoxapine-induced tardive dyskinesia following discontinuation of amoxapine therapy is reported. During 68 weeks of therapy, the patient received a maximum of amoxapine 400 mg/d. Six months after amoxapine discontinuation, the patient continued to have symptoms of tardive dyskinesia. These symptoms correlate with the dopamine receptor-blocking property of amoxapine and its metabolites. We propose that amoxapine therapy be monitored for the long-term as well as the short-term adverse effects of dopamine receptor-blockade.
Subject(s)
Amoxapine/adverse effects , Dibenzoxazepines/adverse effects , Dyskinesia, Drug-Induced/etiology , Substance Withdrawal Syndrome/etiology , Aged , Humans , Male
2.
Chin Med J (Engl)
; 98(1): 57-64, 1985 Jan.
Article
in English
| MEDLINE
| ID: mdl-3924500